In November 2018, the United Kingdom enacted legislation for Cannabis-Based Products for Medicinal use in humans (CBPMs) through the Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales, and Scotland) Regulations 2018.
Read the Report
